Search results

Order by most recent / most popular / relevance

Results: 11-20 of 391

Annual report reveals need for biotech shift in focus to demonstrate drug value

Shook Hardy & Bacon LLP
-
USA
-
May 2 2013

According to Ernst & Young's 27th annual biotechnology industry report, the global biotechnology industry has continued its recovery, but small and

$13.6 billion deal to merge rival genetic-sequencing machine companies

Shook Hardy & Bacon LLP
-
USA
-
April 18 2013

Thermo Fisher Scientific has reportedly agreed to purchase Life Technologies Corp. for $13.6 billion in a deal expected to close in early 2014

U.S. intervenes in False Claims Act suit against biotech company

Shook Hardy & Bacon LLP
-
USA
-
April 4 2013

The U.S. government has intervened in part of a False Claims Act (FCA) lawsuit against Agave BioSystems, a biotechnology-based small business with

Ninth Circuit to consider impact of trial court error in admitting expert testimony

Shook Hardy & Bacon LLP
-
USA
-
April 4 2013

In related cases that could have implications for intellectual property, consumer safety and complex litigation where resolution of the dispute

Genetic technologies settles infringement suit over non-DNA coding technology

Shook Hardy & Bacon LLP
-
USA
-
May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms

House appropriators concerned about sequestration of FDA user fees

Shook Hardy & Bacon LLP
-
USA
-
May 2 2013

Food and Drug Administration (FDA) Commissioner Margaret Hamburg reportedly testified before a House Appropriations Subcommittee about the effects of

Nabsys secures financing to develop electronic DNA sequencing technology

Shook Hardy & Bacon LLP
-
USA
-
March 21 2013

Nabsys, a gene-sequencing startup, has reportedly secured $20 million in a Series D financing round. The Providence, Rhode Island-based company says

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

Shook Hardy & Bacon LLP
-
European Union
-
May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

PolyMedix expects to raise $25 million for antibiotic development

Shook Hardy & Bacon LLP
-
USA
-
March 21 2013

PolyMedix, Inc. stockholders have overwhelmingly approved a reverse stock split of the company's common stock at a ratio of up to fifty-for-one

Support growing for request that FDA freeze biosimilar applications

Shook Hardy & Bacon LLP
-
USA
-
February 21 2013

The Washington Legal Foundation (WLF), a public interest law and policy center, has filed comments with the U.S. Food and Drug Administration (FDA

< back next >

Search results

Annual report reveals need for biotech shift in focus to demonstrate drug value

$13.6 billion deal to merge rival genetic-sequencing machine companies

U.S. intervenes in False Claims Act suit against biotech company

Ninth Circuit to consider impact of trial court error in admitting expert testimony

Genetic technologies settles infringement suit over non-DNA coding technology

House appropriators concerned about sequestration of FDA user fees

Nabsys secures financing to develop electronic DNA sequencing technology

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

PolyMedix expects to raise $25 million for antibiotic development

Support growing for request that FDA freeze biosimilar applications

Current Search

Suggested Facets

Author

Jurisdiction

Workarea